KVLQT1—a long QT syndrome gene

Details KVLQT1—a long QT syndrome gene KVLQT1—a long QT syndrome gene

2005-12-06

2005-12-06

Ulm, John (Department: 1646)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

Reexamination Certificate

active

06972176

ABSTRACT:
The genomic structure including the sequence of the intron/exon junctions is disclosed for KVLQT1 and KCNE1 which are genes associated with long QT syndrome. Additional sequence data for the two genes ARE also disclosed. Also disclosed are newly found mutations in KVLQT1 which result in long QT syndrome. The intron/exon junction sequence data allow for the design of primer pairs to amplify and sequence across all of the exons of the two genes. This can be used to screen persons for the presence of mutations which cause long QT syndrome. Assays can be performed to screen persons for the presence of mutations in either the DNA or proteins. The DNA and proteins may also be used in assays to screen for drugs which will be useful in treating or preventing the occurrence of long QT syndrome.

REFERENCES:
patent: 2335599 (1999-09-01), None
patent: 9723598 (1997-07-01), None
patent: WO 9817292 (1998-04-01), None
patent: WO 0033824 (2000-06-01), None
patent: WO 0040258 (2000-07-01), None
patent: WO 0056348 (2000-09-01), None
Ackerman, M.J. “The Long QT Syndrome: Ion Channel Disease of the Heart”,Mayo Clin. Proc.,1998; 73:250-269.
Barhanin J. et al. “Homo sapiens kidney and cardiac voltage dependent K+ channel (KvLQT1) mRNA, complete cds”, GenBank Accession No. AF000571.1; 1997.
Benhorin,J. et al. “Evidence of Genetic Heterogeneity in the Long QT Syndrome”,Science,Jun. 25, 1993; 260:1960-1962.
Bulman “Phenotype variation and newcomers in ion channel disorders”,Human Molecular Genetics,1997; 6(10) Review:1679-1685.
Chouabe, C. et al. “Properties of KVLQT1 K+channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias”,The EMBO Journal,1997; 16(17):5472-5479.
Coonar, et al. “Molecular Genetics of Familial Cardiomyopathies”,Advances in Genetics,1997; 35:285-324.
Curran, M. et al. “Locus Heterogeneity of Autosomal Dominant Long QT Syndrome”,J. Clin. Invest.,Aug. 1993; 92:799-803.
de Jager, et al. “Evidence of a long QT founder gene with varying phenotypic expression in South African families”,J. Med. Genet.,1996; 33:567-573.
Donger, C. et al. “KVLQT1 C-Terminal Missense Mutation Causes a Forme Fruste Long-QT Syndrome”,Circulation,1997; 96:2778-2781.
Hoffman, et al. “Ion Channels-13 Molecular Divining Rods Hit Their Clinical Mark”,New England Journal of Medicine,May 29, 1997; 336(22):1599-1600.
Itoh, T. et al. “Genomic organization and mutational analysis of KVLQT1, a gene responsible for familial long QT syndrome”,Hum. Genet.,1998; 103:290-294.
Keating, et al. “Consistent Linkage of the Long-QT Syndrome to the HarveyRas-I Locus on Chromosome II”,Am. J. Hum. Genet.,1991; 49:1335-1339.
Keating, M. “Linkage Analysis and Long QT Syndrome Using Genetics to Study Cardiovascular Disease”,Circulation,1992, 85:1973-1986.
Keating, et al. “Linkage of a Cardiac Arrhythmia, the Long QT Syndrome, and the Harveyras-1 Gene”,Science,May 3, 1991;252:704-706.
Komsuoglu, et al. “The Jervell and Lange-Nielsen syndrome”,International Journal of Cardiology,1994; 47:189-192.
Larsen, L.A., et al. “High-Throughput Single-Strand Conformation Polymorphism Analysis by Automated Capillary Electrophoresis: Robust Multiplex Analysis and Pattern-Based Identification of Allelic Variants”,Human Mutation,1999; 13:318-327.
Lee, et al. “Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Weidemann Syndrome chromosomal rearrangements”,Nature Genetics,Feb. 1997; 15:181-185.
Liu, et al. “New Mutations in the KVLQT1 Potassium Channel That Cause Long-QT Syndrome”,Circulation,1998; 97:1264-1269.
Mannens, et al. “KVLQT1, the rhythm of imprinting”,Nature Genetics,Feb. 1997; 15:113-115.
Marx, J. “Rare Heart Disease Linked to Oncogene”,Research News,May 3, 1991; p. 647.
Neyroud, et al. “A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Neilsen cardioauditory syndrome”,Nature Genetics,Feb. 1997; 15:186-189.
Priori, S.G. “Is long QT syndrome entering the era of molecular diagnosis?”,Heart,1997; 77:5-6.
Priori, et al. “A Recessive Variant of the Romano-Ward Long-QT Syndrome?”,Circulation,1998; 97:2420-2425.
Rakaf, et al. Case Report—“Jervell and Lange-Nielsen QT syndrome: a case report from Saudi Arabia”,International Journal of Pediatric Otorhinolaryngology,1997; 39:163-168.
Romey, G. et al. “Molecular Mechanism and Functional Significance of the MinK Control of the KVLQT1 Channel Activity”,The Journal of Biological Chemistry;Jul. 4, 1997; 272(27):16713-16716.
Rosen. “Long QT Syndrome Patients with Gene Mutations”,Circulation,1995; 92:3373-3375.
Russell, M.W. et al. “KVLQT1 mutations in three families with familial or sporadic long QT syndrome”,Human Molecular Genetics;1996; 5(9):1319-1324.
Saarinen, et al. “Molecular Genetics of the Long QT Syndrome: Two Novel Mutations of the KVLQT1 Gene and Phenotypic Expression of the Mutant Gene in a Large Kindred”,Human Mutation,1998; 11:158-165.
Sanguinetti, M.C. et al. “Coassembly of KVLQT1 and minK (IsK) proteins to form cardiac IKSpotassium channel”,Nature,Nov. 7, 1996; 384:80-83.
Sanguinetti, et al. “Review—Potassium Channelopathies”,Neuropharmacology,1997; 36(6):755-762.
Shimizu, et al. “Improvement of Repolarization Abnormalities by a K+Chanel Opener in the LQT1 Form of Congential Long-QT Syndrome”,Circulation,1998; 97:1581-1588.
Splawski, et al. “Molecular Basis of the Long-QT Syndrome Associated with Deafness”,The New England Journal of Medicine,May 29, 1997; 336(22):1562-1567.
Tanaka, et al. “Four Novel KVLQT1 and Four Novel HERG Mutations in Familial Long-QT Syndrome”,Circulation,Feb. 4, 1997; 95(3):565-567.
Towbin, J.A. et al. “Evidence of Genetic Heterogeneity in Romano-Ward Long QT Syndrome”,Circulation,1994; 90:2635-2644.
Tyson, J. et al. “IsK and KVLQT1: mutation in either of the two subunits of the slow component of the delayed rectifier potassium channel can cause Jervell and Lange-Nielsen syndrome”,Human Molecular Genetics,1997; 6(12):2179-2185.
van den Berg et al. “The long QT Syndrome: a novel missense mutation in the S6 region of the KVLQT1 gene”,Hum. Genet.,1997; 100:356-361.
Vincent “Genetics and Molecular Biology of the Inherited Long QT Syndrome”,Annals of Medicine,1994; 26:419-425.
Vincent “The Molecular Genetics of the Long QT Syndrome: Genes causing fainting and sudden death”,Annu. Rev. Med.,1998; 49:263-274.
Wang, Q. et al. “Molecular genetics of long AT syndrome from genes to patients”,Current Opinion in Cardiology,1997; 12:310-320.
Wang, Q. et al. “Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias”,Nature Genetics,Jan. 1996; 12:17-23.
Wollnik, et al. “Pathophysiologicl mechanisms of dominant and recessive KVLQT1 K+channel mutaations found in inherited cardiac arrhythmias”,Human Molecular Genetics,1997; 6(11):1943-1949.
Yang, et al. “KVLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias”,Proc. Natl. Acad. Sci. USA,Apr. 1997; 94:4017-4021.
Yang et al. “Human voltage-gated potassium channel KvLQT1 (KVLQT1) mRNA, partial cds”, GenBank Accession No. U86146; 1997.

Affiliated with

Also associated with

Rating

KVLQT1—a long QT syndrome gene does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with KVLQT1—a long QT syndrome gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and KVLQT1—a long QT syndrome gene will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3500229